FDA warns Gilead over 'misleading' paid search link

The FDA warned Gilead ($GILD) about a paid search link for its drug Viread with the title "Hepatitis B Prevention." The drug is approved for treating--not preventing--hepatitis B, prompting FDA to call the advert misleading. FDA was also critical of the lack of risk information. Article | Letter (PDF)